Skip to main content

CASE REPORT article

Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1456293

Successful PGT-M based on the identification of a spliceogenic variant in the RPGRIP1L gene through Minigene assay Huiling Xu 1 (ORCID: 0000-0002-6835-7693), Jiajie Pu 2 (ORCID: 0000-0002-3638-9228)

Provisionally accepted
  • 1 Reproductive Medicine Center, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China
  • 2 Department of Bioinformatics, 01life Institute, Shenzhen, China

The final, formatted version of the article will be published soon.

    With the development of high-throughput sequencing, the genetic etiology of many diseases has been revealed. However, this has also led to the categorization of many variants as variants of uncertain significance (VUSs), presenting a major challenge in genetic counseling. A couple with a history of adverse pregnancies sought assisted reproductive technology. Trio-WES revealed that they individually carried the following variants in the RPGRIP1L gene: a c.1581G>A (p.Gln527=) (VUS) and a c.135-11A>G (likely pathogenic variant, LP). Further investigation using the Minigene assay showed that the variant c.1581G>A (p.Gln527=) disrupts the normal splicing pattern of the mRNA, leading to two abnormal splicing modes: 1) retention of 26 bp in intron 13; 2) exon 13 skipping transcript. Consequently, the VUS was reclassified as likely pathogenic. We then performed preimplantation genetic testing (PGT) for the couple, which included direct detection of the RPGRIP1L locus, SNP haplotype analysis, and chromosome copy number detection. Through these precise detection procedures, an unaffected embryo was selected for transfer, and the prenatal genetic diagnosis of the fetus was normal. Our study indicates that the Minigene assay is a valuable tool for splicing functional analysis of variants in vitro. This approach is particularly useful for genetic counseling involving VUS that may affect pre-mRNA splicing, as well as for the subsequent clinical management of the related family.

    Keywords: RPGRIP1L gene, Minigene, mRNA splicing, PGT-M, VUS

    Received: 28 Jun 2024; Accepted: 03 Oct 2024.

    Copyright: © 2024 Xu, Pu, Wu, Guo and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Shuhan Guo, Reproductive Medicine Center, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China
    Xuemei Li, Reproductive Medicine Center, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.